Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGLV6-57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TJAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MTG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC7A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LZTS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNRPB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIER2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPALPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105379178 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
L2HGDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRA2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFXAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on